Non Invasive Blood Glucose Monitoring Devices Market In-depth Research covering sales outlook, demand forecast & up-to-date key trends
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Non Invasive Blood Glucose Monitoring Devices market is expected to grow at a CAGR of 16.5% during the forecast period.
The global Non Invasive Blood Glucose Monitoring Devices market is estimated to be about 7.1 million US dollars in 2020.
The global Non Invasive Blood Glucose Monitoring Devices market is estimated to reach 12.1 million USD by 2026.
The global Non Invasive Blood Glucose Monitoring Devices market is segmented by company, region (country), type and application. Participants, stakeholders, and other readers in the global Non Invasive Blood Glucose Monitoring Devices market will be able to gain an advantage as they use reports as a powerful resource.
Non Invasive Blood Glucose Monitoring Devices markets by category
MIR/NIR (Mid/Near Infrared Spectroscopy)
Raman Spectroscopy
Occlusion Spectroscopy
Optical Coherence Tomography
Photoacoustic Spectroscopy
Electromagnetic
Fluorescence
Other
Non Invasive Blood Glucose Monitoring Devices Market by Application (Percentage of Demand)
Hospitals
Clinics
Home Care Settings
Other
Who are the leading companies in Non Invasive Blood Glucose Monitoring Devices
Abbott
BD Medical
Medtronic
Sanofi
Roche Diagnostics
Animas Technologies
Bayer Healthcare
Cercacor
Pendragon Medical
OrSense
Nova Biomedical
Dexcom
Terumo
Tosoh Bioscience
Non Invasive Blood Glucose Monitoring Devices markets by region:
In North America
In Latin America
Europe
The Asia-pacific
Middle East and Africa (MEA)
What are the main countries covered
The United States
Canada
Germany
France
UK
Italy
Russia
China
Japan
Korea
Southeast Asia
India
Australia
Brazil
Mexico
Argentina
Chile
Colombia
Egypt
Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Which is the most profitable market
Among regions, North America/Europe/Asia Pacific accounted for the largest share of global personalized beauty equipment as rising consumer incomes led to increased spending at Non Invasive Blood Glucose Monitoring Devices.
What methodology did you follow in your research
This study was conducted by our expert analysts through a combination of primary and secondary studies. The methodology we follow includes a demand-side assessment of the market and triangulation of this through supply-side analysis. The methodology is based on the use of standard market structures, methods, and definitions.
Who were the primary study respondents
We talk to stakeholders across the spectrum. Including C-level executives, distributors, product manufacturers, industry experts, etc.
What are the sources of secondary research
We conduct extensive secondary studies using proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations and research papers.
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Market Size Units
1.8 Review Cycle
2 Global Market Overview
2.1 Global Non Invasive Blood Glucose Monitoring Devices Revenue and Growth Forecast 2014-2026
2.2 Global Non Invasive Blood Glucose Monitoring Devices Market Size and Growth Forecast 2014-2026
2.3 Global Non Invasive Blood Glucose Monitoring Devices Revenue by Region 2014-2026
2.4 Non Invasive Blood Glucose Monitoring Devices Market Share by Major Regions 2014-2021
2.5 Non Invasive Blood Glucose Monitoring Devices Gross Margin in Different Region 2014-2021
2.6 Global Non Invasive Blood Glucose Monitoring Devices Market History Price and Forecast 2014-2026
2.7 Global Non Invasive Blood Glucose Monitoring Devices Sales Market Share by Top Companies 2014-2021
3 Global Non Invasive Blood Glucose Monitoring Devices Market by Type
3.1 Global Non Invasive Blood Glucose Monitoring Devices Revenue and Growth Rate Segment by Types from 2014-2021
3.2 Global Non Invasive Blood Glucose Monitoring Devices Market Size and Growth Rate Segment by Product Types from 2014-2021
3.3 Global Non Invasive Blood Glucose Monitoring Devices Price Segment by Types from 2014-2021
3.4 Brief Introduction of Different Types
3.4.1 MIR/NIR (Mid/Near Infrared Spectroscopy)
3.4.2 Raman Spectroscopy
3.4.3 Occlusion Spectroscopy
3.4.4 Optical Coherence Tomography
3.4.5 Photoacoustic Spectroscopy
3.4.6 Electromagnetic
3.4.7 Fluorescence
3.4.8 Other
4 Global Non Invasive Blood Glucose Monitoring Devices Market by Application
4.1 Global Non Invasive Blood Glucose Monitoring Devices Revenue and Growth Rate Segment by Applications from 2014-2021
4.2 Global Non Invasive Blood Glucose Monitoring Devices Market Size and Growth Rate Segment by Product Applications from 2014-2021
4.3 Brief Introduction of Different Applications
4.3.1 Hospitals
4.3.2 Clinics
4.3.3 Home Care Settings
4.3.4 Other
5 North America Non Invasive Blood Glucose Monitoring Devices Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
5.1 North America Non Invasive Blood Glucose Monitoring Devices Value ($) from 2014-2021
5.2 North America Non Invasive Blood Glucose Monitoring Devices Market Size from 2014-2021
5.3 North America Non Invasive Blood Glucose Monitoring Devices Price Change from 2014-2021
5.4 North America Non Invasive Blood Glucose Monitoring Devices Import and Export from 2014-2021
5.5 North America Non Invasive Blood Glucose Monitoring Devices Market Value ($) and Growth (%) by Type from 2014-2021
5.6 North America Non Invasive Blood Glucose Monitoring Devices Market Value ($) and Growth (%) by Application from 2014-2021
5.7 North America Non Invasive Blood Glucose Monitoring Devices Market Value ($) and Growth (%) by Countries from 2014-2021
5.7.1 The United States
5.7.2 Canada
5.8 Top North America Non Invasive Blood Glucose Monitoring Devices Participants Value ($) and Market Share (%) in 2020
6 Europe Non Invasive Blood Glucose Monitoring Devices Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
6.1 Europe Non Invasive Blood Glucose Monitoring Devices Value ($) from 2014-2021
6.2 Europe Non Invasive Blood Glucose Monitoring Devices Market Size from 2014-2021
6.3 Europe Non Invasive Blood Glucose Monitoring Devices Price Change from 2014-2021
6.4 Europe Non Invasive Blood Glucose Monitoring Devices Import and Export from 2014-2021
6.5 Europe Non Invasive Blood Glucose Monitoring Devices Market Value ($) and Growth (%) by Type from 2014-2021
6.6 Europe Non Invasive Blood Glucose Monitoring Devices Market Value ($) and Growth (%) by Application from 2014-2021
6.7 Europe Non Invasive Blood Glucose Monitoring Devices Market Value ($) and Growth (%) by Countries from 2014-2021
6.7.1 Germany
6.7.2 France
6.7.3 UK
6.7.4 Italy
6.7.5 Russia
…
6.8 Top Europe Non Invasive Blood Glucose Monitoring Devices Participants Value ($) and Market Share (%) in 2020
7 Asia-Pacific Non Invasive Blood Glucose Monitoring Devices Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
7.1 Asia-Pacific Non Invasive Blood Glucose Monitoring Devices Value ($) from 2014-2021
7.2 Asia-Pacific Non Invasive Blood Glucose Monitoring Devices Market Size from 2014-2021
7.3 Asia-Pacific Non Invasive Blood Glucose Monitoring Devices Price Change from 2014-2021
7.4 Asia-Pacific Non Invasive Blood Glucose Monitoring Devices Import and Export from 2014-2021
7.5 Asia-Pacific Non Invasive Blood Glucose Monitoring Devices Market Value ($) and Growth (%) by Type from 2014-2021
7.6 Asia-Pacific Non Invasive Blood Glucose Monitoring Devices Market Value ($) and Growth (%) by Application from 2014-2021
7.7 Asia-Pacific Non Invasive Blood Glucose Monitoring Devices Market Value ($) and Growth (%) by Countries from 2014-2021
7.7.1 China
7.7.2 Japan
7.7.3 Korea
7.7.4 Southeast Asia
7.7.5 India
7.7.6 Australia
…
7.8 Top Asia-Pacific Non Invasive Blood Glucose Monitoring Devices Participants Value ($) and Market Share (%) in 2020
8 Latin America Non Invasive Blood Glucose Monitoring Devices Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
8.1 Latin America Non Invasive Blood Glucose Monitoring Devices Value ($) from 2014-2021
8.2 Latin America Non Invasive Blood Glucose Monitoring Devices Market Size from 2014-2021
8.3 Latin America Non Invasive Blood Glucose Monitoring Devices Price Change from 2014-2021
8.4 Latin America Non Invasive Blood Glucose Monitoring Devices Import and Export from 2014-2021
8.5 Latin America Non Invasive Blood Glucose Monitoring Devices Market Value ($) and Growth (%) by Type from 2014-2021
8.6 Latin America Non Invasive Blood Glucose Monitoring Devices Market Value ($) and Growth (%) by Application from 2014-2021
8.7 Latin America Non Invasive Blood Glucose Monitoring Devices Market Value ($) and Growth (%) by Countries from 2014-2021
8.7.1 Brazil
8.7.2 Mexico
8.7.3 Argentina
8.7.4 Chile
8.7.5 Colombia
…
8.8 Top Latin America Non Invasive Blood Glucose Monitoring Devices Participants Value ($) and Market Share (%) in 2020
9 Middle East & Africa Non Invasive Blood Glucose Monitoring Devices Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
9.1 Middle East & Africa Non Invasive Blood Glucose Monitoring Devices Value ($) from 2014-2021
9.2 Middle East & Africa Non Invasive Blood Glucose Monitoring Devices Market Size from 2014-2021
9.3 Middle East & Africa Non Invasive Blood Glucose Monitoring Devices Price Change from 2014-2021
9.4 Middle East & Africa Non Invasive Blood Glucose Monitoring Devices Import and Export from 2014-2021
9.5 Middle East & Africa Non Invasive Blood Glucose Monitoring Devices Market Value ($) and Growth (%) by Type from 2014-2021
9.6 Middle East & Africa Non Invasive Blood Glucose Monitoring Devices Market Value ($) and Growth (%) by Application from 2014-2021
9.7 Middle East & Africa Non Invasive Blood Glucose Monitoring Devices Market Value ($) and Growth (%) by Countries from 2014-2021
9.7.1 Egypt
9.7.2 Saudi Arabia
9.7.3 United Arab Emirates
9.7.4 Nigeria
9.7.5 South Africa
…
9.8 Top Middle East & Africa Non Invasive Blood Glucose Monitoring Devices Participants Value ($) and Market Share (%) in 2020
10. Global Level Competitive Intelligence – Company Profiles
10.1 Abbott
10.1.1 Abbott Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.1.2 Abbott Sales, Value, Gross and Gross Margin from 2014-2021
10.1.3 Abbott Value and Growth Change from 2014-2021
10.1.4 Abbott Price Change from 2014-2021
10.1.5 Abbott Product Offered
10.2 BD Medical
10.2.1 BD Medical Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.2.2 BD Medical Sales, Value, Gross and Gross Margin from 2014-2021
10.2.3 BD Medical Value and Growth Change from 2014-2021
10.2.4 BD Medical Price Change from 2014-2021
10.2.5 BD Medical Product Offered
10.3 Medtronic
10.3.1 Medtronic Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.3.2 Medtronic Sales, Value, Gross and Gross Margin from 2014-2021
10.3.3 Medtronic Value and Growth Change from 2014-2021
10.3.4 Medtronic Price Change from 2014-2021
10.3.5 Medtronic Product Offered
10.4 Sanofi
10.4.1 Sanofi Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.4.2 Sanofi Sales, Value, Gross and Gross Margin from 2014-2021
10.4.3 Sanofi Value and Growth Change from 2014-2021
10.4.4 Sanofi Price Change from 2014-2021
10.4.5 Sanofi Product Offered
10.5 Roche Diagnostics
10.5.1 Roche Diagnostics Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.5.2 Roche Diagnostics Sales, Value, Gross and Gross Margin from 2014-2021
10.5.3 Roche Diagnostics Value and Growth Change from 2014-2021
10.5.4 Roche Diagnostics Price Change from 2014-2021
10.5.5 Roche Diagnostics Product Offered
10.6 Animas Technologies
10.6.1 Animas Technologies Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.6.2 Animas Technologies Sales, Value, Gross and Gross Margin from 2014-2021
10.6.3 Animas Technologies Value and Growth Change from 2014-2021
10.6.4 Animas Technologies Price Change from 2014-2021
10.6.5 Animas Technologies Product Offered
10.7 Bayer Healthcare
10.7.1 Bayer Healthcare Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.7.2 Bayer Healthcare Sales, Value, Gross and Gross Margin from 2014-2021
10.7.3 Bayer Healthcare Value and Growth Change from 2014-2021
10.7.4 Bayer Healthcare Price Change from 2014-2021
10.7.5 Bayer Healthcare Product Offered
10.8 Cercacor
10.8.1 Cercacor Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.8.2 Cercacor Sales, Value, Gross and Gross Margin from 2014-2021
10.8.3 Cercacor Value and Growth Change from 2014-2021
10.8.4 Cercacor Price Change from 2014-2021
10.8.5 Cercacor Product Offered
10.9 Pendragon Medical
10.9.1 Pendragon Medical Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.9.2 Pendragon Medical Sales, Value, Gross and Gross Margin from 2014-2021
10.9.3 Pendragon Medical Value and Growth Change from 2014-2021
10.9.4 Pendragon Medical Price Change from 2014-2021
10.9.5 Pendragon Medical Product Offered
10.10 OrSense
10.10.1 OrSense Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.10.2 OrSense Sales, Value, Gross and Gross Margin from 2014-2021
10.10.3 OrSense Value and Growth Change from 2014-2021
10.10.4 OrSense Price Change from 2014-2021
10.10.5 OrSense Product Offered
10.11 Nova Biomedical
10.11.1 Nova Biomedical Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.11.2 Nova Biomedical Sales, Value, Gross and Gross Margin from 2014-2021
10.11.3 Nova Biomedical Value and Growth Change from 2014-2021
10.11.4 Nova Biomedical Price Change from 2014-2021
10.11.5 Nova Biomedical Product Offered
10.12 Dexcom
10.12.1 Dexcom Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.12.2 Dexcom Sales, Value, Gross and Gross Margin from 2014-2021
10.12.3 Dexcom Value and Growth Change from 2014-2021
10.12.4 Dexcom Price Change from 2014-2021
10.12.5 Dexcom Product Offered
10.13 Terumo
10.13.1 Terumo Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.13.2 Terumo Sales, Value, Gross and Gross Margin from 2014-2021
10.13.3 Terumo Value and Growth Change from 2014-2021
10.13.4 Terumo Price Change from 2014-2021
10.13.5 Terumo Product Offered
10.14 Tosoh Bioscience
10.14.1 Tosoh Bioscience Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.14.2 Tosoh Bioscience Sales, Value, Gross and Gross Margin from 2014-2021
10.14.3 Tosoh Bioscience Value and Growth Change from 2014-2021
10.14.4 Tosoh Bioscience Price Change from 2014-2021
10.14.5 Tosoh Bioscience Product Offered
11. Market Dynamics
11.1 Driving Factors
11.1.1 Rising Demand in Some Regions: North America/Europe/China/India/Japan …
11.1.2 Increasing Use of Non Invasive Blood Glucose Monitoring Devices by Different End-User/Applications
11.2 Restraints and Challenges in the Market
11.3 Opportunities
11.4 Covid-19 Impact/Evaluation
12. Future Forecast of Global Non Invasive Blood Glucose Monitoring Devices Market from 2020-2026
12.1 Future Forecast of Global Non Invasive Blood Glucose Monitoring Devices Market from 2020-2026 Segment by Regions
12.2 Future Forecast of Global Non Invasive Blood Glucose Monitoring Devices Market from 2020-2026 Segment by Type
12.3 Future Forecast of Global Non Invasive Blood Glucose Monitoring Devices Market from 2020-2026 Segment by Application
13. Investment Analysis
13.1 Fundamental Analysis (Porter's Five Forces Analysis)
13.2 Technical Preparation Analysis
13.3 Risk Evaluating Analysis
13.4 Estimated Investment Pay-Back Period
14 Research Methodology
14.1 Research Data
14.1.1 Secondary Data
14.1.2 Primary Data
14.2 Revenue Estimation
14.2.1 Bottom-Up Approach
14.2.2 Top-Down Approach (Involves time, Space, and Persons)
14.3 Data Triangulation
14.4 Assumptions
14.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
14.6 Limitations of Our Study
14.7 Scene Based Modeling
15 Disclaimer
Research Methodology:
Non Invasive Blood Glucose Monitoring Devices Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|